References
- Guidelines for the diagnosis and management of asthma. National Asthma Education and Prevention Program, National Heart, Lung and Blood Institute, National Institutes of Health. Guidelines for the Diagnosis and Management of Asthma. National Institutes of Health, Bethesda, MD. Asthma Expert Panel Report 3 NAEPP Guidelines, 2007. Available at: www.nhlbi.nih.gov/guidelines/asthma/asthgdln.pdf [Last accessed 9 December 2008]
- Dahl R, Chuchalin A, Gor D, et al. EXCEL: a randomised trial comparing salmeterol/fluticasone propionate and formoterol/budesonide combinations in adults with persistent asthma. Respir Med 2006;100:1152-62
- Buhl R, Vogelmeier C. Budesonide/formoterol maintenance and reliever therapy: a new treatment approach for adult patients with asthma. Curr Med Res Opin 2007;23:1867-78
- Nelson HS, Weiss ST, Bleecker ER, et al. for the SMART Study Group. The Salmeterol Multicenter Asthma Research Trial: a comparison of usual pharmacotherapy for asthma or usual pharmacotherapy plus salmeterol. Chest 2006;129:15-26
- United States Department of Health and Human Services, Food and Drug Administration. FDA Public Health Advisory. Serevent Diskus (salmeterol xinafoate inhalation powder), Advair Diskus (fluticasone propionate & salmeterol inhalation powder), Foradil Aerolizer (formoterol fumarate inhalation powder). Updated May 15, 2006. Available at: www.fda.gov/cder/drug/advisory/LABA.htm [Last accessed 27 January 2009]
- Symbicort Inhalation Aerosol [package insert]. Wilmington, DE: AstraZeneca LP; 2009
- Advair Diskus [package insert]. Research Triangle Park, NC: GlaxoSmithKline; 2009
- Friedman H, Wilcox T, Reardon G, et al. A retrospective study of the use of fluticasone propionate/salmeterol combination as initial asthma controller therapy in a commercially insured population. Clin Ther 2008;30:1908-17
- Breton MC, Lelorier J, Forget A, et al. Use of combination therapy in asthma: are they prescribed according to guidelines. Respir Med 2007;101:1916-23
- Charlson ME, Pompei P, Ales KL, et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chron Dis 1987;40:373-83
- Deyo RA, Cherkin DC, Ciol MA. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol 1992;45:613-19
- Schatz M, Camargo CA Jr. Follow-up after an asthma hospitalization: who can prevent subsequent exacerbations?. Chest 2006;130:8-10
- Schatz M, Zeiger RS, Vollmer WM, et al. Development and validation of a medication intensity scale derived from computerized pharmacy data that predicts emergency hospital utilization for persistent asthma. Am J Manag Care 2006;12:478-84
- Schatz M, Nakahiro R, Jones CH, et al. Asthma population management: development and validation of a practical 3-level risk stratification scheme. Am J Manag Care 2004;10:25-32
- Schatz M, Cook EF, Joshua A, et al. Risk factors for asthma hospitalizations in a managed care organization: development of a clinical prediction rule. Am J Manag Care 2003;9:538-47
- Adams RJ, Smith BJ, Ruffin RE. Factors associated with hospital admissions and repeat emergency department visits for adults with asthma. Thorax 2000;55:566-73
- Taylor BW. The identification of high risk asthmatic children using the emergency department asthma visit count. J Emerg Med 1999;17:953-6
- Dales RE, Schweitzer I, Kerr P, et al. Risk factors for recurrent emergency department visits for asthma. Thorax 1995;50:520-4
- Anis AH, Lynd LD, Wang XH, et al. Double trouble: impact of inappropriate use of asthma medication on the use of health care resources. CMAJ 2001;164:625-31
- Schatz M, Nakahiro R, Crawford W, et al. Asthma quality of care markers using administrative data. Chest 2005;128:1968-73
- Friedman HS, Yawn BP. Resource utilization in asthma: combined fluticasone propionate/salmeterol compared with inhaled corticosteroids. Curr Med Res Opin 2007;23:427-34
- Colice GL, Yu AP, Ivanova JI, et al. Costs and resource use of mild persistent asthma patients initiated on controller therapy. J Asthma 2008;45:293-9
- Navaratnam P, Jayawant S, Pedersen CA, et al. Physician adherence to the national asthma prescribing guidelines: evidence from national outpatient survey data in The United States. Ann Allergy Asthma Immunol 2008;100:216-21
- Allen Ramey FC, Samet JM, Rand CS, et al. Trends in use of inhaled corticosteroids for asthma management: 1994–1998. Ann Epidemiol 2004;14:161-7